Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
about
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeTips for teachers of evidence-based medicine: understanding odds ratios and their relationship to risk ratiosConstitutive reactive oxygen species generation from autophagosome/lysosome in neuronal oxidative toxicity.Stroke management.Erythropoietin in the prevention of experimental burn progression.Development of thrombolytic therapy for stroke: a perspective.Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury.Biomarkers of proteolytic damage following traumatic brain injury.The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?Use of MRI in the identification and treatment of early ischemic stroke lesions.Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.The application of diffusion- and perfusion-weighted magnetic resonance imaging in the diagnosis and therapy of acute cerebral infarction.Targeting ischemic brain injury with intravenous immunoglobulin.Inhibition of tissue factor expression in brain microvascular endothelial cells by nanoparticles loading NF-kappaB decoy oligonucleotides.Partial XBP1 knockdown does not affect viability of oligodendrocyte precursor cells exposed to new models of hypoxia and ischemia in vitro.Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion.Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours.Separation of perfusion signals from diffusion-weighted image series enabled by independent component analysis.Neural Vascular Mechanism for the Cerebral Blood Flow Autoregulation after Hemorrhagic Stroke.Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats.Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator.Therapeutic results of intra-arterial thrombolysis after full-dose intravenous tissue plasminogen activator administration.A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
P2860
Q30414441-ED9387D8-1D28-44EE-96DB-59F448AD803EQ30481737-782558AE-411A-4722-B3A2-81707A8C254CQ33581452-C922DCAA-B69E-457E-920E-210F81F1335FQ33928297-7997F013-9F4C-49AA-8A6D-3FA203940E6CQ34350719-42A6A52A-8F9C-4044-ABAB-F54BF8EB90BFQ35001038-5DB06E82-EEFD-4CDD-AEC2-2FF11249B1F1Q35628458-1DE8A2DB-B2FA-43C3-8730-D61401F28298Q35802481-B277DE45-C983-4289-BA10-0307E09497E8Q35842504-F66F62C1-6C8E-4A04-9615-F1672C07E762Q35856305-A18BA5FE-9AA2-4DB3-8913-755F9BCAE43AQ35992243-808ACAF4-EE80-4D67-8762-6A9BCB1A3B2DQ36106814-7503E5C1-71BE-4039-AA49-90DED66D6487Q36572422-D32AF1EE-9F15-4663-9BE4-2EA3C317FA0BQ37030865-C9A50B25-9D21-4D50-8836-7382388E3995Q37083517-8DAD842B-5866-475B-87E7-2166034B4B80Q39588814-A43C5B5D-47D2-4B17-A686-054FB8823105Q42841826-93CBEFFF-54CF-49A1-9D51-4FBEAA05F49EQ44961282-C38D13A5-086B-4C16-90EA-B72AE0B56E4CQ45799877-E3079FB4-30D7-4C6C-A6BF-790D9DB697FDQ47124231-1DBFBC43-57E1-4DD8-82E2-EF1A84BF3B42Q48109512-73045342-DAFA-4E18-A174-3F457F8A617FQ48153483-3E1BB937-7EB8-4629-AB68-DE35FDD350D0Q48235501-4E5FD881-056D-484C-B802-7D4AD4BCAAA1Q48492472-3708EC7D-25D9-44AB-A017-3A6C773A5145
P2860
Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@ast
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@en
type
label
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@ast
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@en
prefLabel
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@ast
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@en
P2093
P1433
P1476
Thrombolytic therapy within 3 ...... mic stroke: useful or harmful?
@en
P2093
P A Ringleb
P D Schellinger
P304
P356
10.1161/01.STR.0000015555.21285.DB
P407
P577
2002-05-01T00:00:00Z